At the closing bell, the S&P/ASX 200 was 0.9 per cent or 63 points higher at 7,355. Health care stocks boosted further in the afternoon, with CSL (ASX:CSL) up 5.2 per cent and Australian Clinical Labs (ASX:ACL) up 12.2 after upgrading its earnings forecast. Across the sector, Sonic Healthcare (ASX:SHL) rose 2.5 per cent, Nanosonics (ASX:NAN) rose 7.5 per cent, Cochlear (ASX:COH) rose 3.85 per cent and Telix Pharameuticals (ASX:TLX) rose 9.3 per cent following its first patient dosed in a bladder cancer study.